Pure water revolution: China's new rules reduce WFI energy demand by up to 80%

80 % less energy. Zero steam. Complete safety.
The new era of WFI generation is here - sustainable, efficient, recognized by the regulator.

In the context of increasing ESG requirements and rising energy costs, every kilowatt in pharmaceutical production is coming into focus. From October 2025, the Chinese Pharmacopoeia (CHP) will allow the production of water for injection (WFI) using cold membrane processes for the first time - a step that was already taken in Europe in 2017. As the energy-intensive phase change is no longer necessary, both consumption and the carbon footprint are significantly reduced. Those who deal with the concept, suppliers and qualification at an early stage gain a real cost and sustainability advantage - supported by partners who think about planning and implementation from a single source, like pixon.

Read our full article HERE

‍